Lupin launches Varenicline Tablets in the US
It is indicated for use as an aid to smoking cessation treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Healthcare industry reported 84 deals worth $38.6 billion, in Dec 2023
Deal value increased by 4.4 per cent in Dec 2023, compared to Dec 2022
Supriya Lifescience gets GMP certification from ANVISA Brazil
ANVISA certification will help Supriya Lifescience to strategically grow its footprint in the Brazilian pharmaceutical sector and…
Hikal, Gujarat govt ink MoU at Vibrant Gujarat Summit
Under the terms of the MoU, Hikal invests Rs 500 crores into the existing fine chemical plant at Panoli, Gujarat
Biotech funding recovery is on the horizon in 2024: GlobalData
40 per cent of healthcare industry professionals surveyed globally expressed an optimistic or very optimistic sentiment on the …
UP govt to build a 1472-acre pharma park in Lalitpur, Bundelkhand
The identified villages for the survey include Saidpur (426 acres), Gadolikala (249 acres), Largan (239 acres), Karounda (116…
Lupin launches Second Edition of Aptivate Champion Run for Kids
It promotes children’s well-being through fitness and nutrition
Caplin Steriles gets USFDA approval for Ofloxacin Otic Solution
Ofloxacin Otic Solution 0.3% is used as anti-infective (antibacterial) for otic (ear) use
MoHFW announces revised Schedule M under the Drugs (Amendment) Rules, 2023
Small and medium manufacturers with an annual turnover of less than Rs 250 crore have 12 months to comply with the guidelines,…
Akums launches Lasmiditan Tablet for migraine management
The medication is formulated to interrupt pain signals to the brain and address nerve inflammation contributing to migraine…
MDD market across 8MM to reach $9.6 bn by 2029 driven by novel drug launches: GlobalData
Some of the key unmet needs in the MDD market are for products that have improved efficacy and safety profiles and that can show…
Pharma supply chain: From fragile to agile
Sharmishtha Niyogi, Supply Chain Director at Merck, sheds light on the pivotal role of advanced technologies, strategic…
Strong performance in US market to support Indian pharma’s growth in FY2024: ICRA
Revenues of ICRA’s sample set of companies to expand by 9-11 per cent in FY2024, OPM to improve by 150-200 bps to 22-23 per cent…
Age-related macular degeneration market across 7MM set to reach $27.5 bn in 2031: GlobalData
Therapies with longer treatment intervals are a dominant trend in the AMD pipeline
Navigating the seas of change: Leadership in the age of disruption
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) opines that leadership in this era of…
Dr Reddy’s acquires MenoLabs, women’s health and dietary supplements portfolio of brands
MenoLabs portfolio of products is sold in the US, primarily through the brand’s own and other e-commerce marketplaces including…
Glenmark launches biosimilar of anti-diabetic drug, Liraglutide, in India
It is priced at around Rs 100 for a standard dose of 1.2 mg (per day)
Will 2024 be a year of regulatory renaissance?
2024 will thus be a year to rebuild trust in the CDSCO, with more stringent regulations, coupled with stricter implementation of…
BDR Pharma launches BDENZA oral solution for prostate cancer
BDENZA will be available at Rs 27,000 for 150mL
Alembic Pharma received eight USFDA approvals in Q3FY24
The company has received five final approvals and three tentative approvals